Logo image of CTOS

CUSTOM TRUCK ONE SOURCE INC (CTOS) Stock Fundamental Analysis

NYSE:CTOS - New York Stock Exchange, Inc. - US23204X1037 - Common Stock - Currency: USD

4.62  -0.18 (-3.75%)

After market: 4.62 0 (0%)

Fundamental Rating

2

CTOS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 48 industry peers in the Trading Companies & Distributors industry. CTOS has a bad profitability rating. Also its financial health evaluation is rather negative. CTOS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CTOS has reported negative net income.
CTOS had a positive operating cash flow in the past year.
In multiple years CTOS reported negative net income over the last 5 years.
Of the past 5 years CTOS 4 years had a positive operating cash flow.
CTOS Yearly Net Income VS EBIT VS OCF VS FCFCTOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.12%, CTOS is doing worse than 83.33% of the companies in the same industry.
With a Return On Equity value of -4.79%, CTOS is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
The Return On Invested Capital of CTOS (4.52%) is worse than 70.83% of its industry peers.
CTOS had an Average Return On Invested Capital over the past 3 years of 3.85%. This is significantly below the industry average of 9.88%.
The last Return On Invested Capital (4.52%) for CTOS is above the 3 year average (3.85%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.12%
ROE -4.79%
ROIC 4.52%
ROA(3y)-1.31%
ROA(5y)-2.01%
ROE(3y)-3.74%
ROE(5y)N/A
ROIC(3y)3.85%
ROIC(5y)3.92%
CTOS Yearly ROA, ROE, ROICCTOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 50 100 150 200

1.3 Margins

CTOS's Operating Margin of 7.28% is in line compared to the rest of the industry. CTOS outperforms 47.92% of its industry peers.
In the last couple of years the Operating Margin of CTOS has grown nicely.
The Gross Margin of CTOS (22.11%) is worse than 75.00% of its industry peers.
In the last couple of years the Gross Margin of CTOS has remained more or less at the same level.
Industry RankSector Rank
OM 7.28%
PM (TTM) N/A
GM 22.11%
OM growth 3Y8.07%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5YN/A
CTOS Yearly Profit, Operating, Gross MarginsCTOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

CTOS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CTOS has been reduced compared to 1 year ago.
CTOS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CTOS has been reduced compared to a year ago.
CTOS Yearly Shares OutstandingCTOS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CTOS Yearly Total Debt VS Total AssetsCTOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

CTOS has an Altman-Z score of 0.73. This is a bad value and indicates that CTOS is not financially healthy and even has some risk of bankruptcy.
CTOS's Altman-Z score of 0.73 is on the low side compared to the rest of the industry. CTOS is outperformed by 87.50% of its industry peers.
A Debt/Equity ratio of 1.87 is on the high side and indicates that CTOS has dependencies on debt financing.
The Debt to Equity ratio of CTOS (1.87) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.87
Debt/FCF N/A
Altman-Z 0.73
ROIC/WACC0.41
WACC11.06%
CTOS Yearly LT Debt VS Equity VS FCFCTOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

CTOS has a Current Ratio of 1.28. This is a normal value and indicates that CTOS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CTOS (1.28) is worse than 85.42% of its industry peers.
A Quick Ratio of 0.19 indicates that CTOS may have some problems paying its short term obligations.
CTOS's Quick ratio of 0.19 is on the low side compared to the rest of the industry. CTOS is outperformed by 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.19
CTOS Yearly Current Assets VS Current LiabilitesCTOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

CTOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -157.14%.
Measured over the past years, CTOS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.65% on average per year.
The Revenue has decreased by -1.46% in the past year.
The Revenue has been growing by 83.33% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-157.14%
EPS 3YN/A
EPS 5Y-13.65%
EPS Q2Q%-275%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y83.33%
Revenue growth 5YN/A
Sales Q2Q%2.96%

3.2 Future

The Earnings Per Share is expected to decrease by -34.72% on average over the next years. This is quite bad
CTOS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.59% yearly.
EPS Next Y-191.95%
EPS Next 2Y-43.32%
EPS Next 3Y-34.72%
EPS Next 5YN/A
Revenue Next Year0.7%
Revenue Next 2Y1.34%
Revenue Next 3Y3.59%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTOS Yearly Revenue VS EstimatesCTOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CTOS Yearly EPS VS EstimatesCTOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CTOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CTOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTOS Price Earnings VS Forward Price EarningsCTOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTOS is valued a bit cheaper than the industry average as 79.17% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.3
CTOS Per share dataCTOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

CTOS's earnings are expected to decrease with -34.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.32%
EPS Next 3Y-34.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTOS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUSTOM TRUCK ONE SOURCE INC

NYSE:CTOS (2/21/2025, 8:11:15 PM)

After market: 4.62 0 (0%)

4.62

-0.18 (-3.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)03-04 2025-03-04/amc
Inst Owners25.94%
Inst Owner Change-99.2%
Ins Owners2.53%
Ins Owner Change0.29%
Market Cap1.08B
Analysts81.67
Price Target6.29 (36.15%)
Short Float %6.43%
Short Ratio5.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-347.92%
Min EPS beat(2)-553.59%
Max EPS beat(2)-142.24%
EPS beat(4)0
Avg EPS beat(4)-263.95%
Min EPS beat(4)-553.59%
Max EPS beat(4)-39.8%
EPS beat(8)3
Avg EPS beat(8)-100.22%
EPS beat(12)5
Avg EPS beat(12)33.86%
EPS beat(16)7
Avg EPS beat(16)-140.69%
Revenue beat(2)0
Avg Revenue beat(2)-5.91%
Min Revenue beat(2)-9.62%
Max Revenue beat(2)-2.21%
Revenue beat(4)1
Avg Revenue beat(4)-3.56%
Min Revenue beat(4)-11.56%
Max Revenue beat(4)9.13%
Revenue beat(8)5
Avg Revenue beat(8)3.33%
Revenue beat(12)6
Avg Revenue beat(12)0.59%
Revenue beat(16)9
Avg Revenue beat(16)1.73%
PT rev (1m)0%
PT rev (3m)-6.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF 91.77
P/B 1.29
P/tB N/A
EV/EBITDA 7.3
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-1.46
FCFYN/A
OCF(TTM)0.05
OCFY1.09%
SpS7.73
BVpS3.59
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.12%
ROE -4.79%
ROCE 5.29%
ROIC 4.52%
ROICexc 4.53%
ROICexgc 7.43%
OM 7.28%
PM (TTM) N/A
GM 22.11%
FCFM N/A
ROA(3y)-1.31%
ROA(5y)-2.01%
ROE(3y)-3.74%
ROE(5y)N/A
ROIC(3y)3.85%
ROIC(5y)3.92%
ROICexc(3y)3.87%
ROICexc(5y)3.94%
ROICexgc(3y)6.78%
ROICexgc(5y)6.9%
ROCE(3y)4.52%
ROCE(5y)4.59%
ROICexcg growth 3Y27.45%
ROICexcg growth 5YN/A
ROICexc growth 3Y29.91%
ROICexc growth 5YN/A
OM growth 3Y8.07%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5YN/A
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.87
Debt/FCF N/A
Debt/EBITDA 4.33
Cap/Depr 153.24%
Cap/Sales 19.56%
Interest Coverage 0.74
Cash Conversion 3.25%
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.19
Altman-Z 0.73
F-Score4
WACC11.06%
ROIC/WACC0.41
Cap/Depr(3y)136.29%
Cap/Depr(5y)127.75%
Cap/Sales(3y)19.11%
Cap/Sales(5y)24.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-157.14%
EPS 3YN/A
EPS 5Y-13.65%
EPS Q2Q%-275%
EPS Next Y-191.95%
EPS Next 2Y-43.32%
EPS Next 3Y-34.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y83.33%
Revenue growth 5YN/A
Sales Q2Q%2.96%
Revenue Next Year0.7%
Revenue Next 2Y1.34%
Revenue Next 3Y3.59%
Revenue Next 5YN/A
EBIT growth 1Y-30.21%
EBIT growth 3Y98.12%
EBIT growth 5YN/A
EBIT Next Year88.28%
EBIT Next 3Y32.21%
EBIT Next 5YN/A
FCF growth 1Y-41.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.35%
OCF growth 3YN/A
OCF growth 5YN/A